Aberrant expression of MECOM is one of the characteristic features of many malignancies including leukemia [55] and solid tumors such as breast cancer and hepatocellular carcinoma [53, 56] as well as lung cancer [57]. This evidence concerns the gene MECOM and lung carcinoma.